Telomere biology in cardiovascular disease - role of insulin sensitivity in diabetic hearts.
The present study examined telomere biology in the context of insulin sensitivity in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a type 2 diabetic animal model. To improve insulin sensitivity, pioglitazone (PG; 10 mg/kg/day) was administered to OLETF rats between 20 weeks and 40 weeks of age, and the effects of the treatment were compared with those in untreated OLETF rats or control Long-Evans Tokushima Otsuka rats. The homeostasis model assessment of insulin resistance index significantly increased in OLETF rats, but decreased in PG-treated OLETF rats. Telomere lengths were not shortened in heart tissues of OLETF rats; however, telomerase activity was decreased in heart tissues of OLETF rats. Messenger RNA expression for both telomerase reverse transcriptase and telomere repeat binding factor 2 was downregulated in the hearts of OLETF rats. Protein expression of phosphorylated Akt, insulin-like growth factor and endothelial nitric oxide synthase were all reduced in OLETF rats. The changes observed in OLETF rats were inhibited by PG treatment. Myocardial fibrosis was less extensive and diastolic dysfunction improved in PG-treated OLETF rats versus untreated OLETF rats. These findings suggest that improving insulin sensitivity via the activation of peroxisome proliferator-activated receptor-gamma may exert regulatory effects on cardiac telomere biology, and may have desirable morphological and functional effects on the diabetic heart.
Division of Molecular and Clinical Gerontology, Department of Molecular and Cellular Biology;
Naoki
N
Makino
Makoto
M
Sasaki
Toyoki
T
Maeda
Kosi
K
Mimori
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1379-84
18467646
Lancet. 2007 Jan 13;369(9556):107-14
17223473
Circ Res. 2004 Mar 19;94(5):575-84
15031270
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1165-71
18388332
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):842-6
12649083
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6622-6
3413114
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1165-H1176
18641273
Circ Res. 2005 Sep 30;97(7):663-73
16141414
Am J Epidemiol. 2007 Jan 1;165(1):14-21
17043079
Nat Chem Biol. 2007 Oct;3(10):640-9
17876321
Circulation. 2005 May 3;111(17):2171-7
15851602
J Mol Cell Cardiol. 1999 Sep;31(9):1607-15
10471345
Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):487-93
14648808
Aging Cell. 2004 Jun;3(3):97-102
15153177
Circ Res. 2004 Mar 5;94(4):514-24
14726476
Circ Res. 2006 Nov 24;99(11):1167-80
17122447
Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2188-95
19855065
Diabetes Care. 2006 Feb;29(2):283-9
16443874
Genes Dev. 2005 Sep 15;19(18):2100-10
16166375
Neurosci Lett. 2004 Jun 3;363(1):94-6
15158005
Aging Cell. 2007 Oct;6(5):709-13
17725691
Proc Natl Acad Sci U S A. 1995 May 23;92(11):4818-22
7761406
Clin Sci (Lond). 2009 May 01;116(11):827-35
19090788
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5378-83
12702777